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INTRODUCTION:  Paragangliomas  are  rare  tumors  arising  from  neural  crest  tissue  located  outside  the
adrenal  gland.  Primary  seminal  vesicle  paraganglioma  is  extremely  rare  entity.
PRESENTATION OF CASE:  A 26-year-old  male  patient  presented  with  symptoms  and  signs  of  acute  appen-
dicitis  where  a CT  of  abdomen  and  pelvis  showed  an  inﬂamed  appendix  and incidental  ﬁnding  of left
seminal  vesicle  mass.  The patient  underwent  uneventful  laparoscopic  appendectomy  followed  by tran-
srectal  ultrasound  (TRUS)  guided  seminal  vesicle  biopsies.  Histopathology  revealed  a neuroendocrine
neoplasm  consistent  with  paraganglioma.  Surgical  excision  of the left  seminal  vesicle  was  carried  out.
DISCUSSION: Paraganglioma  of genitourinary  tract  is  rare.  The  urinary  bladder  is  the  most  common  site,
followed  by the  urethra,  pelvis  and  ureter.  Seminal  vesicle  paragangliomas  were  reported  in  associa-
tion  with  other  genitourinary  organ  involvement  such  as  bladder  and  prostate.  Isolated  seminal  vesicle
paraganglioma  is extremely  rare and  surgical  excision  remains  the standard  treatment  for  localized
paraganglioma.
CONCLUSION:  Primary  tumors  of seminal  vesicle  are  rare  and  represent  a diagnostic  challenge.  Differential
diagnosis  includes  a  list  of benign  and malignant  tumors.  Primary  seminal  vesicle  paraganglioma  is  a rare
but  important  diagnosis  to  be included  in the differential  diagnosis.
© 2013 The Authors. Published by Elsevier Ltd on behalf of Surgical Associates Ltd. . Introduction
Extra-adrenal paragangliomas are tumors that arise from neural
rest cells or organs. They are most frequently found in the organ
f Zuckerkandl, but can be found anywhere along the sympathetic
hain. Generally paraganglioma are slow growing benign tumors,
lthough malignant degeneration and distant metastases has been
escribed. Seminal vesicle paragangliomas have been reported in
ssociation with bladder and prostate involvement, but as primary
eminal vesicle paraganglioma there was only one case reported in
edical literature to the best of our knowledge.
. Case report
A 26-year-old male patient with unremarkable past medi-
al and surgical history, presented to accident and emergency
epartment with symptoms and signs of acute appendicitis
here a CT with contrast of abdomen and pelvis showed an
nﬂamed appendix and incidental ﬁnding of left enhancing seminal
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ttp://dx.doi.org/10.1016/j.ijscr.2013.07.009vesicle mass (Fig. 1). The patient underwent uneventful laparo-
scopic appendectomy then referred to our care. A transrectal
ultrasound (TRUS) guided seminal vesicle biopsies was done
and the patient did not experience any symptoms or signs of
catecholamine overproduction. Histopathology and immunohisto-
chemistry revealed a neuroendocrine neoplasm most consistent
with paraganglioma. The tumor cells stain strongly positive with
chromogranin and synaptophysin. They show strong cytoplasmic
staining for Myo-D1 (non-speciﬁc) and weak cytoplasmic staining
for CD117. S100 highlights the sustentacular cells around the cellu-
lar nests. Inhibin, HMB-45, CD31, desmin, SMA, CKAE1/AE3, CD34
and calretinin were negative.
Work up for functional paraganglioma was carried out; the
24-h urinary catacholamine metabolites were within the nor-
mal range. The patient then underwent surgical exploration and
excision of the left seminal vesicle. Macroscopically, the seminal
vesicle was  brownish in color with soft to ﬁrm in consistency,
measuring 2 × 2 × 1.3 cm,  and weighing 8.80 g. Microscopically,
nests of cuboidal cells separated by vascular ﬁbrous septa with-
out evidence of vascular invasion, mitotic ﬁgures or necrosis. The
surgical margins were free from tumor. A panel of immunohis-
tochemistry was  done. Chromogranin, synaptophysin and CD56
are positive in tumor cells and S100 was positive in sustentacu-
Open access under CC BY-NC-ND license.lar cells. These ﬁndings conﬁrm the diagnosis of paraganglioma.
Follow-up imaging with CT scan done one year after surgery
showed no evidence of local recurrence or distant metastasis
(Fig. 2).
s Ltd. Open access under CC BY-NC-ND license.
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Fig. 1. CT (A and B) and MRI  (C and D) of abdomen and pelvis: showing a well-deﬁned rounded left SV (arrow) enhancing necrotic mass measuring 2.7 × 2.7 × 2.9 cm. (D)
The  lesion appears hyperintense on T2 and shows signiﬁcant enhancement on the post contrast images mainly at its periphery. No regional lymphadenopathy or invasion of
the  adjacent structures. Bladder (B) and rectum (R).
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pig. 2. Follow-up CT scan of abdomen and pelvis one year post-operatively showing
etastasis. Bladder (B) and rectum (R).
. Discussion
Extra-adrenal paragangliomas are rare neuroendocrine tumors
hat arise from neural crest-derived endocrine cells anywhere
long the sympathetic chain. Nearly 85% of paragangliomas are
ntra-abdominal, 12% are intrathoracic, and 3% are cervical. Para-
angliomas may  occur at unusual locations, including the kidneys,
rethra, urinary bladder, prostate, spermatic cord, gallbladder,
terus and vagina.3 In the genitourinary tract, the urinary blad-
er is the most common site for paraganglioma (79.2%), followed
y the urethra (12.7%), pelvis (4.9%), and ureter (3.2%).10,11 Fur-
hermore, approximately 10% of all extra adrenal paraganglioma
re malignant.11 The histogenesis of paragangliomas of the sper-
atic cord is unknown, although it has been speculated that
araganglion nests in the spermatic cord may  be secondary to
ysgenesis during embryogenesis.3 The origin of seminal vesi-
le paraganglioma can be explained in the same way as for the
permatic cord, because the cells that give rise to the semi-
al vesicle originate in the caudal Wolfﬁan duct and urogenital
inus.1,3 Histologically, paragangliomas show similar morphologic
haracteristics. They exhibit a pattern of cell clusters (Zellballen)
urrounded by ﬁne ﬁbrovascular septa. Immunohistochemistry for
euroendocrine markers are positive for synaptophysin, chromo-
ranin A, and CD 56. Protein S100 highlights the sustentacular
nd tumor cells.13 The distinction between benign and malig-
ant paraganglioma represent a diagnostic challenge. Clinical
arameters proposed to predict malignancy include higher uri-
ary catecholamine metabolites such as VMA  and dopamine, an
xtra-adrenal tumor location, large tumor size, and persistent
ostoperative hypertension.2 Histopathological ﬁndings of tumorcal clips (arrow) at the site of left SV with no evidence of local recurrence or distant
necrosis, vascular invasion, capsular invasion and high mitotic
ﬁgures indicate malignancy. The only currently accepted mean
to deﬁne malignant paraganglioma is the presence of metastatic
deposits at non-chromafﬁn sites.5 Currently, there is no standard
staging system for paraganglioma. The clinical presentation of para-
gangliomas is highly variable, largely depending on the size and
location of the lesion, as well as the functional status of the tumor.
If the tumor is functional, the patient may  experience symptoms
and signs of catecholamine overproduction, such as hypertension,
headaches, palpitations, sweating, tachycardia and anxiety, and
may  be precipitated by an inciting event depending on its location
such as micturition in case of bladder paraganglioma. The labora-
tory diagnosis of functional paragangliomas is made by detecting
an elevation of the 24-h urinary of catecholamine metabolites
and vanillylmandelic acid levels.4,6–9 Whereas in non-functional
tumors, the diagnosis may  not be made until an advanced stage
due to asymptomatic presentation or nonspeciﬁc symptoms or as
an incidentloma as in our case. Treatment options of paragan-
glioma include catecholamine blockade, surgery, chemotherapy,
radiofrequency ablation, cryoablation and radiation therapy. The
standard treatment for localized or locally advanced paraganglioma
is surgery while unresectable or metastatic tumors are treated with
palliative therapy.12
4. ConclusionsExtra-adrenal paragangliomas are rare neuroendocrine tumors.
In the genitourinary tract, the urinary bladder is the most common
site for paraganglioma. Primary seminal vesicle paraganglioma
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s extremely rare with only one reported case in literature.
 second case of primary seminal vesicle paraganglioma pre-
ented.
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